Verified Nov 2026
Other
·

Jersey City, New Jersey
·
Since 2016
Mitsubishi Tanabe Pharma Development America, headquartered in Jersey City, New Jersey and founded in 2016, is a subsidiary of Tanabe Pharma Corporation with 200–500 employees and estimated annual revenue between $1–5 billion. The company develops and commercializes pharmaceutical products for North American markets, focusing on serious and rare diseases including amyotrophic lateral sclerosis, multiple sclerosis, and diabetes. It markets RADICAVA (edaravone) for ALS treatment.
Mitsubishi Tanabe Pharma Development America at a glance
Revenue
$1-5B
Est. band
Employees
200-500
Founded
2016
Headquarters
Jersey City, New Jersey
Industries
Automotive
Electric Vehicles
Medical
Overview
Mitsubishi Tanabe Pharma Development America, headquartered in Jersey City, New Jersey and founded in 2016, is a subsidiary of Tanabe Pharma Corporation with 200–500 employees and estimated annual revenue between $1–5 billion. The company develops and commercializes pharmaceutical products for North American markets, focusing on serious and rare diseases including amyotrophic lateral sclerosis, multiple sclerosis, and diabetes. It markets RADICAVA (edaravone) for ALS treatment.
At a glance
Attribute | Detail |
|---|---|
Founded | 2016 |
Headquarters | Jersey City, New Jersey |
Employees | 200-500 |
Revenue | $1-5B (estimated) |
What Mitsubishi Tanabe Pharma Development America makes
The company specializes in commercializing approved pharmaceuticals for therapeutic areas including amyotrophic lateral sclerosis, multiple sclerosis, and diabetes mellitus.
Products and capabilities described on the company's own site include Pump (source: tanabe-pharma.com).
Latest developments
2026-08-18 — Individual Press Releases - Tanabe Pharma America (tanabe-pharma.com)
2026-05-14 — Bain-backed Tanabe Pharma targets three new drug launches a year in Japan | MarketScreener (marketscreener.com)
2025-12-23 — Shionogi to buy Jersey City pharma for $2.5B (njbiz.com)
2025-12-01 — Shionogi Expands Rare Disease Presence with Planned Acquisition of Global Rights to Tanabe Pharma Corporation’s RADICAVA ORS® (edaravone) and IV RADICAVA| Shionogi, Inc. (shionogi.com)
2025-09-05 — Mitsubishi Tanabe Pharma Latest Drugmaker to Place 340B Contract Pharmacy Restrictions, Others Add New Drugs, State Exemptions - 340B Report (340breport.com)
Company details
Tanabe Pharma America is a subsidiary of the Japan-based Tanabe Pharma Corporation and serves the North American healthcare market with focus on rare disease treatments. Mitsubishi Tanabe Pharma Development America was founded in 2016, has an estimated 200-500 employees, and is headquartered in Jersey City, New Jersey.
Frequently asked questions
What does Mitsubishi Tanabe Pharma Development America do?
Mitsubishi Tanabe Pharma Development America, headquartered in Jersey City, New Jersey and founded in 2016, is a subsidiary of Tanabe Pharma Corporation with 200–500 employees and estimated annual revenue between $1–5 billion. The company develops and commercializes pharmaceutical products for North American markets, focusing on serious and rare diseases including amyotrophic lateral sclerosis, multiple sclerosis, and diabetes. It markets RADICAVA (edaravone) for ALS treatment.
Where is Mitsubishi Tanabe Pharma Development America headquartered?
Mitsubishi Tanabe Pharma Development America is headquartered in Jersey City, New Jersey (525 Washington Boulevard, Jersey City, New Jersey, 07310).
When was Mitsubishi Tanabe Pharma Development America founded?
Mitsubishi Tanabe Pharma Development America was founded in 2016.
How big is Mitsubishi Tanabe Pharma Development America?
Mitsubishi Tanabe Pharma Development America has an estimated 200-500 employees, with revenue in the $1-5B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
